title: Genetic susceptibility to hemorrhagic complications during warfarin therapy.
authors.affiliation: Department of Surgery, Burn, Trauma, Surgical Critical Care Section, and the Molecular Diagnostic Laboratory, Washington University School of Medicine, St Louis, Mo.
authors.forename: A R
authors.initials: AR
authors.lastname: Tabrizi
authors.forename: B D
authors.initials: BD
authors.lastname: Freeman
authors.forename: T G
authors.initials: TG
authors.lastname: Buchman
authors.forename: B A
authors.initials: BA
authors.lastname: Zehnbauer
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D001189:Aryl Hydrocarbon Hydroxylases; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006470:Hemorrhage / Q000139:chemically induced* / Q000235:genetics*; D006801:Humans; D007866:Leg; D039181:Steroid 16-alpha-Hydroxylase; D013250:Steroid Hydroxylases / Q000235:genetics*; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D003577:Cytochrome P-450 Enzyme System; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; D039181:Steroid 16-alpha-Hydroxylase